(Q415366)

tirofiban (English)

19 October 2016

C₂₂H₃₆N₂O₅S

1 reference

tirofiban (English)

19 November 2016

CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O

1 reference

tirofiban (English)

19 November 2016

CCCCS(=O)(=O)N[C@@H](CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O

1 reference

parenteral route of administration

tirofiban (English)

19 November 2016

10 milligram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=B01AC17

1 reference

14 February 2018

World Health Organisation international non-proprietary name

tirofiban (English)

1 reference

Tirofiban (English)

medical condition treated

19 January 2016

myocardial infarction

1 reference

arteriosclerotic heart disease

13 December 2016

1 reference

13 December 2016

coronary artery disease

1 reference

13 December 2016

1 reference

significant drug interaction

13 December 2016

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibrutinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anagrelide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fondaparinux

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alteplase

1 reference

A reference set of clinically relevant adverse drug-drug interactions

subject has role

fibrinolytic agents

1 reference

Medical Subject Headings

MeSH descriptor ID

C078823

platelet aggregation inhibitors

15 March 2018

1 reference

InChI=1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1

Medical Subject Headings

15 March 2018

Tirofiban

0 references

Identifiers

InChI

1 reference

tirofiban (English)

19 November 2016

2 references

tirofiban (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

144494-65-5

2 references

tirofiban (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=144494-65-5

8 April 2021

1 reference

Tirofiban (English)

19 November 2016

2 references

tirofiban (English)

19 November 2016

40466968

1 reference

Reaxys registry number

6182267

1 reference

tirofiban (English)

19 October 2016

mapping relation type

3 references

TIROFIBAN (English)

19 November 2016

ChEBI release 2019-10-02

International Chemical Identifier

InChI

InChI=1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1

1 reference

TIROFIBAN (English)

19 November 2016

2 references

inferred from InChIKey

Hazardous Substances Data Bank

1 reference

1 reference

28 October 2019

TIROFIBAN (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Tirofiban (English)

CAS no.: 144494-65-5 (English)

ECHA Substance Infocard ID

100.163.548

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Tirofiban (English)

CAS no.: 144494-65-5 (English)

1 reference

Guide to Pharmacology Ligand ID

Tirofiban (English)

publication date

17 November 2015

6586

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

6586

tirofiban (English)

19 November 2016

Tirofiban

0 references

MeSH tree code

D12.125.072.050.875.875

0 references

RxNorm ID

73137

1 reference

tirofiban (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014913

2 references

based on heuristic

inferred from InChIKey

2 references

tirofiban (English)

19 November 2016

NDF-RT ID

N0000022121

1 reference

tirofiban (English)

19 November 2016

0 references

1 reference

1 reference

tirofiban (English)

19 October 2016

1 reference

Immune Epitope Database and Analysis Resource

tirofiban (English)

19 October 2016

1 reference

1 March 2022

0 references

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

2VDM (English)

19 October 2016

1 reference